Covalent Binding of Xenobiotics to Specific Proteins in the Liver

References

• Pohl L. R. An immunochemical approach of identifying and characterizing protein targets of toxic reactive metabolites. Chem. Res. Toxicol. 1993; 6: 786–793
   PubMed Web of Science ®Google Scholar
• Roberts D. W., Pumford N. R., Potter D. W., Benson R. W., Hinson J. A. A sensitive immunochemical assay for acetaminophen-protein adducts. J. Pharmacol. Exp. Ther. 1987; 241: 527–533
   PubMed Web of Science ®Google Scholar
• Matthews A. M., Roberts D. W., Hinson J. A. N. R. Pumford, Acetaminophen-induced hepatotoxicity: Analysis of total covalent binding versus specific binding to cysteine. Drug Metab. Dispos. 1996; 24: 1192–1196
   PubMed Web of Science ®Google Scholar
• Pumford N. R., Myers T. G., Davila J. C., Highet R. J., Pohl L. R. ldquo;Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac”. Chem. Res. Toxicol. 1993; 6: 147–150
   PubMed Web of Science ®Google Scholar
• Bartolone J. B., Sparks K., Cohen S. D., Khairallah E. A. ldquo;Immunochemical detection of acetaminophen-bound liver proteins”. Biochem. Pharmacol. 1987; 36: 1193–1196
   PubMed Web of Science ®Google Scholar
• Satoh H., Fukuda Y., Anderson D. K., Ferrans V. J., Gillette J. R., Pohl L. R. Immunological studies on the mechanism of halothane-induced hepatotoxicity: Immunohistochemical evidence of trifluoroacetylated hepatocytes. J. Pharmacol. Exp. Ther. 1985; 233: 857–862
   PubMed Web of Science ®Google Scholar
• Halmes N. C., Mc Millan D. C., Oatis J. E.N.R, Jr. Pumford, Immunochemical detection of protein adducts in mice treated with trichloroethylene. Chem. Res. Toxicol. 1996; 9: 451–456
   PubMed Web of Science ®Google Scholar
• Potter D. W., Pumford N. R., Hinson J. A., Benson R. W., Roberts D. W. ldquo;Epitope characterization of acetaminophen bound to protein and nonprotein sulfhydryl groups by an enzyme-linked immunosorbent assay”. J. Pharmacol. Exp. Ther. 1989; 248: 182–189
   PubMed Web of Science ®Google Scholar
• Pumford N. R., Hinson J. A., Potter D. W., Rowland K. L., Benson R. W., Roberts D. W. Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice. J. Pharmacol. Exp. Ther. 1989; 248: 190–196
   PubMed Web of Science ®Google Scholar
• Pumford N. R., Roberts D. W., Benson R. W., Hinson J. A. Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen protein adducts in subcellular liver fractions following a hepatotoxic dose of acetaminophen. Biochem. Pharmacol. 1990; 40: 573–579
   PubMed Web of Science ®Google Scholar
• Roberts D. W., Bucci T. J., Benson R. W., Warbritton A. R., Mc Rae T. A., Pumford N. R., Hinson J. A. Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity. Am. J. Pathol. 1991; 138: 359–371
   PubMed Web of Science ®Google Scholar
• Bartolone J. B., Cohen S. D., Khairallah E. A. ldquo;Immunohistochemical localization of acetaminophen-bound liver proteins”. Fundam. Appl. Toxicol 1989; 13: 859–862
   PubMedGoogle Scholar
• Hargus S. J., Amouzedeh H. R., Pumford N. R., Myers T. G., Mc Coy S. C., Pohl L. R. ldquo;Metabolic activation and immunochemical localization of liver protein adducts of the nonsteroidal anti-inflammatory drug diclofenac”. Chem. Res. Toxicol. 1994; 7: 575–582
   PubMed Web of Science ®Google Scholar
• Satoh H., Gillette J. R., Davies H. W., Schulick R. D., Pohl L. R. ldquo;Immunochemical evidence of trifluoroacetylated cytochrome P-450 in the liver of halothane-treated rats”. Mol. Pharmacol. 1985; 28: 468–474
   PubMed Web of Science ®Google Scholar
• Pumford N. R., Hinson J. A., Benson R. W., Roberts D. W. Immunoblot analysis of protein containing 3-(cystein-S-yl)acetaminophen adducts in serum and subcellular liver fractions from acetaminophen-treated mice. Toxicol. Appl. Pharmacol. 1990; 104: 521–532
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Jollow D. J., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. ldquo;Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism.”. J. Pharmacol. Exp. Ther. 1973; 187: 185–194
   PubMed Web of Science ®Google Scholar
• Jollow D. J., Mitchell J. R., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. ldquo;Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo”. J. Pharmacol. Exp. Ther. 1973; 187: 195–202
   PubMed Web of Science ®Google Scholar
• Bartolone J. B., Birge R. B., Sparks K., Cohen S. D., Khairallah E. A. ldquo;Immunochemical analysis of acetaminophen covalent binding to proteins: Partial characterization of the major acetaminophen-binding liver proteins”. Biochem. Pharmacol. 1988; 37: 4763–4774
   PubMed Web of Science ®Google Scholar
• Pumford N. R., Martin B. M., Hinson J. A. ldquo;A metabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein”. Biochem. Biophys. Res. Commun. 1992; 182: 1348–1355
   PubMed Web of Science ®Google Scholar
• Bartolone J. B., Birge R. B., Bulera S. J., Bruno M. K., Nishanian E. V., Cohen S. D.E.A. Khairallah, Purification, antibody production, and partial amino acid sequence of the 58-kDa acetaminophen-binding liver proteins. Toxicol. Appl. Pharmacol. 1992; 113: 19–29
   PubMed Web of Science ®Google Scholar
• Bansal M. P., Mukhopadhyay T., Scott J., Cook R. G., Mukhopadhyay R., Medina D. ldquo;DNA sequencing of a mouse liver protein that binds selenium: Implications for selenium's mechanism of action in cancer prevention”. Carcinogenesis 1990; 11: 2071–2073
   PubMed Web of Science ®Google Scholar
• Lanfear J., Fleming J., Walker M., Harrison P. ldquo;Different patterns of regulation of the genes encoding the closely related 56 kDa selenium- and acetaminophen-binding proteins in normal tissues and during carcinogenesis”. Carcinogenesis 1993; 14: 335–340
   PubMed Web of Science ®Google Scholar
• Pumford N. R., Halmes N. C., Martin B. M., Cook R. J., Wagner C., Hinson J. A. Covalent binding of acetaminophen to N-10-formyl-tetrahydrofolate dehydrogenase in mice. J. Pharmacol. Exp. Ther. 1997; 280: 501–505
   PubMed Web of Science ®Google Scholar
• Bulera S. J., Birge R. B., Cohen S. D., Khairallah E. A. ldquo;Identification of the mouse liver 44-kDa acetaminophen-binding protein as a subunit of glutamine synthetase”. Toxicol. Appl. Pharmacol. 1995; 134: 313–320
   PubMed Web of Science ®Google Scholar
• Hong M., Cohen S. D., Khairallah E. A. Translocation of the major cytosolic acetaminophen (APAP) protein adducts into the nucleus. Toxicologist 1994; 14: 427
   Google Scholar
• Burcham P. C., Harman A. W. ldquo;Effect of acetaminophen hepatotoxicity on hepatic mitochondrial and microsomal calcium contents in mice”. Toxicol. Lett. 1988; 44: 91–99
   PubMed Web of Science ®Google Scholar
• Burcham P. C., Harman A. W. ldquo;Mitochondrial dysfunction in paracetamol hepatotoxicity: In vitro studies in isolated mouse hepatocytes”. Toxicol. Lett. 1990; 50: 37–48
   PubMed Web of Science ®Google Scholar
• Meyers L. L., Beierschmitt W. P., Khairallah E. A., Cohen S. D. ldquo;Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice”. Toxicol. Appl. Pharmacol. 1988; 93: 378–387
   PubMed Web of Science ®Google Scholar
• Nazareth W. M., Sethi J. K., Mc Lean A. E. ldquo;Effect of paracetamol on mitochondrial membrane function in rat liver slices”. Biochem. Pharmacol. 1991; 42: 931–936
   PubMed Web of Science ®Google Scholar
• Halmes N. C., Hinson J. A., Martin B. M., Pumford N. R. ldquo;Glutamate dehydrogenase covalently binds to a reactive metabolite of acetaminophen”. Chem. Res. Toxicol. 1996; 9: 541–546
   PubMed Web of Science ®Google Scholar
• Kenna J. G., Neuberger J., Williams R. ldquo;Evidence for expression in human liver of halothane-induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis”. Hepatology 1988; 8: 1635–1641
   PubMed Web of Science ®Google Scholar
• Kenna J. G., Neuberger J., Williams R. ldquo;Identification by immunoblotting of three halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis”. J. Pharmacol. Exp. Ther. 1987; 242: 733–740
   PubMed Web of Science ®Google Scholar
• Kenna J. G., Satoh H., Christ D. D., Pohl L. R. ldquo;Metabolic basis for a drug hypersensitivity: Antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane”. J. Pharmacol. Exp. Ther. 1988; 245: 1103–1109
   PubMed Web of Science ®Google Scholar
• Pohl L. R., Thomassen D., Pumford N. R., Butler L. E., Satoh H., Ferrans V. J., Perrone A., Martin B. M., Martin J. L. Hapten carrier conjugates associated with halothane hepatitis. Adv. Exp. Med. Biol. 1990; 283: 111–120
   Google Scholar
• Pohl L. R., Pumford N. R., Martin J. L. Mechanisms, chemical structures, and drug metabolism. Eur. J. Haematol. 1996; 57(Suppl)98–104
   Google Scholar
• Amouzadeh H. R., Pohl L. R. ldquo;Processing of endoplasmic reticulum luminal antigens associated with halothane hepatitis in rat hepatocytes”. Hepatology 1995; 22: 936–943
   PubMed Web of Science ®Google Scholar
• Brown A. P., Gandolfi A. J. Glutathione-S-transferase is a target for covalent modification by a halothane reactive intermediate in the guinea pig liver. Toxicology 1994; 89: 35–47
   PubMed Web of Science ®Google Scholar
• Schapira D., Bassan L., Nahir A. M., Scharf Y. ldquo;Diclofenacinduced hepatotoxicity”. Postgrad. Med. J. 1986; 62: 63–65
   PubMed Web of Science ®Google Scholar
• Sallie R. W., Mc T., Reed W. D., Quinlan M. F., Shilkin K. B. ldquo;Diclofenac hepatitis”. Austr. N. Z. J. Med. 1991; 21: 251–255
   PubMedGoogle Scholar
• Breen E. G., Mc J., Cosgrove E., Mc Cabe J., Stevens F. M. ldquo;Fatal hepatitis associated with diclofenac”. Gut 1986; 27: 1390–1393
   PubMed Web of Science ®Google Scholar
• Dunk A. A., Walt R. P., Jenkins W. J., Sherlock S. S. ldquo;Diclofenac hepatitis”. Br. Med. J. 1982; 284: 1605–1606
   PubMed Web of Science ®Google Scholar
• Helfgott S. M., Sandberg C. J., Zakim D., Nestler J. ldquo;Diclofenac-associated hepatotoxicity”. JAMA 1990; 264: 2660–2662
   PubMed Web of Science ®Google Scholar
• Purcell P., Henry D., Melville G. ldquo;Diclofenac hepatitis”. Gut 1991; 32: 1381–1385
   PubMed Web of Science ®Google Scholar
• Iveson T. J., Ryley N. G., Kelly P. M., Trowell J. M., Mc Gee J. O.R. W. Chapman, Diclofenac associated hepatitis. J. Hepatol. 1990; 10: 85–89
   PubMed Web of Science ®Google Scholar
• Hargus S. J., Martin B. M., George J. W., Pohl L. R. ldquo;Covalent modification of rat liver dipeptidyl peptidase IV (CD26) by the nonsteroidal anti-inflammatory drug diclofenac”. Chem. Res. Toxicol. 1995; 8: 993–996
   PubMed Web of Science ®Google Scholar
• Bruckner J. V., Davis B. D., Blancato J. N. Metabolism, toxicity, and carcinogenicity of trichloroethylene. Crit. Rev. Toxicol. 1989; 20: 31–50
   PubMed Web of Science ®Google Scholar
• Davidson I. W., Beliles R. P. ldquo;Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics”. Drug Metab. Rev. 1991; 23: 493–599
   PubMed Web of Science ®Google Scholar
• Saihan E. M., Burton J. L., Heaton K. W. A new syndrome with pigmentation, scleroderma, gynaecomastia, Raynaud's phenomenon and peripheral neuropathy. Br. J. Dermatol. 1978; 99: 437–440
   PubMed Web of Science ®Google Scholar
• Haustein U. F., Ziegler V. ldquo;Environmentally induced systemic sclerosis-like disorders”. Int. J. Dermatol. 1985; 24: 147–151
   PubMed Web of Science ®Google Scholar
• Lockey J. E., Kelly C. R., Cannon G. W., Colby T. V., Aldrich V., Livingston G. K. ldquo;Progressive systemic sclerosis associated with exposure to trichloroethylene”. J. Occup. Med. 1987; 29: 493–496
   PubMedGoogle Scholar
• Kilburn K. H., Warshaw R. H. ldquo;Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water”. Environ. Res. 1992; 57: 1–9
   PubMed Web of Science ®Google Scholar
• Green T. ldquo;Chloroethylenes: A mechanistic approach to human risk evaluation”. Annu. Rev. Pharmacol. 1990; 30: 73–89
   Google Scholar
• Goeptar A. R., Commandeur J. N. M., van Bladeren B., Ommen P. J., Vermeulen N. P. E. ldquo;Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity: Relevance of the mercapturic acid pathway”. Chem. Res. Toxicol. 1995; 8: 3–21
   PubMed Web of Science ®Google Scholar
• Halmes N. C., Perkins E. J., Mc Millan D. C., Pumford N. R. Detection of trichloroethylene-protein adducts in rat liver and plasma 1996, submitted for publication
   Google Scholar
• Landin J. S., Cohen S. D., Khairallah E. A. ldquo;Identification of a 54-kDa mitochondrial acetaminophen-binding protein as aldehyde dehydrogenase”. Toxicol. Appl. Pharmacol. 1996; 141: 299–307
   PubMed Web of Science ®Google Scholar
• Martin J. L., Kenna J. G., Martin B. M., Thomassen D., Reed G. F., Pohl L. R. ldquo;Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase”. Hepatology 1993; 18: 858–863
   PubMed Web of Science ®Google Scholar
• Martin J. L., Pumford N. R., La Rosa A. C., Martin B. M., Gonzaga H. M., Beaven M. A., Pohl L. R. ldquo;A metabolite of halothane covalently binds to an endoplasmic reticulum protein that is highly homologous to phosphatidylinositol-specific phospholipase C-alpha but has no activity”. Biochem. Biophys. Res. Commun. 1991; 178: 679–683
   PubMed Web of Science ®Google Scholar
• Bourdi M., Demady D., Martin J. L., Jabbour S. K., Martin B. M., George J. W., Pohl L. R. cDNA cloning and baculovirus expression of the human liver endoplasmic reticulum P58: Characterization as a protein disulfide isomerase isoform, but not as a protease or a carnitine acyltransferase. Arch. Biochem. Biophys. 1995; 323: 397–403
   PubMed Web of Science ®Google Scholar
• Satoh H., Martin B. M., Schulick A. H., Christ D. D., Kenna J. G., Pohl L. R. ldquo;Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase”. Proc. Natl. Acad. Sci. USA 1989; 86: 322–326
   PubMed Web of Science ®Google Scholar
• Butler L. E., Thomassen D., Martin J. L., Martin B. M., Kenna J. G., Pohl L. R. ldquo;The calcium-binding protein calreticulin is covalently modified in rat liver by a reactive metabolite of the inhalation anesthetic halothane”. Chem. Res. Toxicol. 1992; 5: 406–410
   PubMed Web of Science ®Google Scholar
• Pumford N. R., Martin B. M., Thomassen D., Burris J. A., Kenna J. G., Martin J. L., Pohl L. R. ldquo;Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein ERp72”. Chem. Res. Toxicol. 1993; 6: 609–615
   PubMed Web of Science ®Google Scholar
• Davila J. C., Pumford N. R., Martin B. M., Thomassen D., Martin J. L., Pohl L. R. A trifluoroacetylated 82 kDa stress protein appears to be a neoantigen associated with halothane hepatitis. Toxicologist 1991; 11: 268
   Google Scholar
• Thomassen D., Martin B. M., Martin J. L., Pumford N. R., Pohl L. R. Characterization of a halothane induced trifluoroacetylated 100 kDa neoantigen that is related to a glucose-regulated protein, FASEB J. 1999; 4
   Google Scholar
• Amouzadeh H. R., Bourdi M., Martin J. L., Martin B. M., Pohl L. R. ldquo;UDP-glucose:gylcoprotein glucosyltransferase associates with endoplasmic reticulum chaperons and its activity is decreased in vivo by the inhalation anesthetic halothane”. Chem. Res. Toxicol. 1997; 10: 59–63
   PubMed Web of Science ®Google Scholar
• Eliasson E., Kenna J. G. ldquo;Cytochrome P450 2E1 is a cell surface autoantigen in halothane”. Mol. Pharmacol. 1996; 50: 573–582
   PubMed Web of Science ®Google Scholar
• Bourdi M., Chen W., Peter R. M., Martin J. L., Buters J. T. M., Nelson S. D., Pohl L. R. ldquo;Human P4502E1 is a major auto-antigen associated with halothane hepatitis and the epitopes are conformational”. Chem. Res. Toxicol. 1996; 9: 1159–1166
   PubMed Web of Science ®Google Scholar
• Brown A. P., Hastings K. L., Gandolfi A. J., Liebler D. C., Brendel K. ldquo;Formation and identification of protein adducts to cytosolic proteins in guinea pig liver slices exposed to halothane”. Toxicology 1992; 73: 281–295
   PubMed Web of Science ®Google Scholar